未登录

R

Randall J. Basaraba

Colorado State University System

H指数:57

被引数:9,814

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune cell infiltration and modulation of the blood-brain barrier in a guinea pig model of tuberculosis: Observations without evidence of bacterial dissemination to the brain

在结核病豚鼠模型中，免疫细胞浸润和血脑屏障的调节：未观察到细菌向大脑扩散的迹象

IF2.6

2024-12-310

OA

Gliosis, misfolded protein aggregation, and neuronal loss in a guinea pig model of pulmonary tuberculosis

FRONTIERS IN NEUROSCIENCE

IF3.2

2023-05-198

OAAI

The Impact of Vitamin A Deficiency on Tuberculosis Progression

CLINICAL INFECTIOUS DISEASES

IF7.3

2022-04-2912

OA

High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation

SCIENTIFIC REPORTS

IF3.9

2021-06-104

OAAI

Metformin enhances anti-mycobacterial responses by educating CD8+T-cell immunometabolic circuits

NATURE COMMUNICATIONS

IF15.7

2020-10-1647

OAAI

Study of Real-Time Spatial and Temporal Behavior of Bacterial Biofilms Using 2-D Impedance Spectroscopy

ieee transactions on circuits and systems i regular papers

IF4.9

2020-10-015

OAAI

Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis

SCIENTIFIC REPORTS

IF3.9

2020-10-0119

OAAI

Cyclin-Dependent Kinases 8 and 19 Regulate Host Cell Metabolism during Dengue Virus Serotype 2 Infection

IF3.5

2020-06-1711

OAAI

A mouse model of pulmonary Mycobacteroides abscessus infection

SCIENTIFIC REPORTS

IF3.9

2020-02-2848

OAAI

2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain

SCIENTIFIC REPORTS

IF3.9

2019-02-0628

OAAI

Analogue synthesis reveals decoupling of antibiofilm and β-lactam potentiation activities of a lead 2-aminoimidazole adjuvant against Mycobacterium smegmatis

CHEMICAL BIOLOGY & DRUG DESIGN

IF3.3

2018-05-1210

OAAI

Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes Part 2: Underlying Biologic mechanisms

IF8.6

2017-07-0165

OAAI

Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes Part 1: Epidemiology and Clinical Management

IF8.6

2017-07-0166

OAAI

Mycobacterial Biofilms: Revisiting Tuberculosis Bacilli in Extracellular Necrotizing Lesions

MICROBIOLOGY SPECTRUM

IF3.8

2017-05-1952

OAAI

Pathology of Tuberculosis: How the Pathology of Human Tuberculosis Informs and Directs Animal Models

MICROBIOLOGY SPECTRUM

IF3.8

2017-05-1913

PREAI

The Discovery of 2-Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β-Lactam Antibiotics in a Pattern Distinct from β-Lactamase Inhibitors

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2017-03-0129

OAAI

A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment

DISEASE MODELS & MECHANISMS

IF3.3

2017-01-0152

OAAI

Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review

SEMINARS IN IMMUNOPATHOLOGY

IF9.2

2015-10-2893

OAAI

Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis

DISEASE MODELS & MECHANISMS

IF3.3

2015-06-01129

OAAI

Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2015-03-2747

OAAI